Physician profile
Cara E Sawyer
NPI 1316218191
$430.92
in general payments reported to CMS, 2019-2025
14 companies · $67.60 in 2025
The $67.60 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.75 · 2020: $32.82 · 2021: $51.73 · 2022: $24.81 · 2023: $60.44 · 2024: $99.77 · 2025: $67.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $84.19 | 2019-2023 | Suflave, Sutab |
| Abbvie INC. | $63.75 | 2023-2025 | Dalvance |
| Ethicon US, LLC | $42.74 | 2019 | |
| Medtronic, INC. | $35.90 | 2021-2023 | Gi Genius |
| Elucent Medical | $30.61 | 2025 | |
| Tela Bio, INC. | $25.95 | 2024 | Ovitex 2s |
| Kerecis Limited | $25.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $24.81 | 2022 | |
| Leica Microsystems INC. | $18.78 | 2020 | |
| Myriad Genetic Laboratories, INC. | $18.11 | 2024 | Myrisk |
| Boston Scientific Corporation | $17.14 | 2024 | Eluvia |
| Allergan, INC. | $15.90 | 2019 | |
| Merck Sharp & Dohme LLC | $14.04 | 2020 | |
| Davol INC. | $13.67 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.